Guided radiation therapy for solid tumors
Part of Cancer clinical trials.
This trial tests a new way to target radiation therapy using PET scans to guide the treatment. It may help people with certain solid tumors by delivering radiation more precisely, possibly reducing damage to healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 21 years or older.
- You have been diagnosed with cancer, either newly or in the past.
- You have at least one tumor (not in the lung or bone) that is between 2 and 5 centimeters in size.
- Your tumor must be active, as confirmed by biopsy or imaging.
- Your tumor must show high uptake on a PET scan, which means it's very active.
- You must be in generally good health (able to care for yourself, but may need some help).
- If you've had other cancer treatments, they must have finished at least 15 days before the study, and you won't start new treatments during the study.
- If you can become pregnant, you must have a negative pregnancy test before starting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether stereotactic (high-precision) radiation given in a few sessions can control rare cancers that have spread to a small number of sites. It aims to help by treating all known spots while keeping side effects manageable.
This study tests a new way to use a PSMA-PET scan (a special imaging test that finds prostate cancer cells) to guide a type of radiation treatment called BgRT. It is for men with prostate cancer who are already getting a PSMA-PET scan as part of their regular care.
This Phase 2 study tests whether using a PET scan to guide focused radiation (SBRT) can control a small number of cancer spots that are starting to grow despite prior treatment. It may help patients avoid wider radiation by targeting only the limited progressing areas.
This study collects information about how you feel and how treatment is delivered while you receive radiotherapy using the RefleXion Medical radiotherapy system. It may help doctors improve care and better understand what affects quality of life during treatment.
This trial tests whether a precise radiation treatment (SBRT) can target a few growing spots of estrogen receptor-positive breast cancer that has spread to other parts of the body. It also uses a special PET scan (FES PET/CT) to see how well the cancer responds. The goal is to slow down the cancer and delay the need for stronger treatments.
This trial tests a single, high-dose radiation treatment (guided by MRI) for people whose cancer has spread to up to 3 spots outside the brain or spine. The goal is to shrink these tumors with one session, potentially helping you live longer or feel better with fewer side effects.
Hear when a new Thoracic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.